CellWell record HH-370492
Efficacy of ursodeoxycholic acid in metabolic dysfunction-associated steatotic liver disease: an umbrella review of meta-analyses on liver enzymes
A. R. Khurmatullina; D. N. Andreev; I. Maev; Andrey V. Zaborovsky; Yury A. Kucheryavyy; P. A. Beliy; P. Sokolov
Frontiers in Medicine ยท 2026
In plain language
Ursodeoxycholic acid consistently reduced liver enzyme markers (ALT, AST, GGT) and cholestatic markers in metabolic dysfunction-associated steatotic liver disease.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-370492
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.